EPISODE · May 23, 2022 · 24 MIN
Chris Dokomajilar on Trends in Life Science Investing, M&A and Partnering
from Rx for Biotech · host Podcast Host Chris Leidli
The biopharma ecosystem is devoting significant resources to develop novel cell and gene therapies to treat cancer. In this episode of "Rx for Biotech", Chris Dokomajilar discusses trends in Biotechnology investment, licensing and partnering landscape and provides an outlook on what to expect for the remainder of 2022.
What this episode covers
The biopharma ecosystem is devoting significant resources to develop novel cell and gene therapies to treat cancer. In this episode of "Rx for Biotech", Chris Dokomajilar discusses trends in Biotechnology investment, licensing and partnering landscape and provides an outlook on what to expect for the remainder of 2022.
NOW PLAYING
Chris Dokomajilar on Trends in Life Science Investing, M&A and Partnering
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Jan 2, 2026 ·47m
Dec 21, 2025 ·46m